Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 90427
MIM: 606266
HGNC: 24132
Ensembl: ENSG00000104081
Variants:
dbSNP: 90427
ClinVar: 90427
TCGA: ENSG00000104081
COSMIC: BMF
RNA/Proteins
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 33149265 | 2021 | The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival. | 14 |
| 33658012 | 2021 | FBW7 suppresses ovarian cancer development by targeting the N(6)-methyladenosine binding protein YTHDF2. | 58 |
| 33149265 | 2021 | The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival. | 14 |
| 33658012 | 2021 | FBW7 suppresses ovarian cancer development by targeting the N(6)-methyladenosine binding protein YTHDF2. | 58 |
| 32620849 | 2020 | Characterization of an alternative BAK-binding site for BH3 peptides. | 14 |
| 32620849 | 2020 | Characterization of an alternative BAK-binding site for BH3 peptides. | 14 |
| 27524613 | 2016 | Genetic Predisposition to Chronic Lymphocytic Leukemia Is Mediated by a BMF Super-Enhancer Polymorphism. | 34 |
| 27539959 | 2016 | Reciprocal regulation of BMF and BIRC5 (Survivin) linked to Eomes overexpression in colorectal cancer. | 16 |
| 27899442 | 2016 | Early generated B1 B cells with restricted BCRs become chronic lymphocytic leukemia with continued c-Myc and low Bmf expression. | 35 |
| 27524613 | 2016 | Genetic Predisposition to Chronic Lymphocytic Leukemia Is Mediated by a BMF Super-Enhancer Polymorphism. | 34 |
| 27539959 | 2016 | Reciprocal regulation of BMF and BIRC5 (Survivin) linked to Eomes overexpression in colorectal cancer. | 16 |
| 27899442 | 2016 | Early generated B1 B cells with restricted BCRs become chronic lymphocytic leukemia with continued c-Myc and low Bmf expression. | 35 |
| 26181206 | 2015 | Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF). | 52 |
| 26181206 | 2015 | Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF). | 52 |
| 24901046 | 2014 | Apolipoprotein L2 contains a BH3-like domain but it does not behave as a BH3-only protein. | 20 |
Citation
Dessen P
BMF (Bcl2 modifying factor)
Atlas Genet Cytogenet Oncol Haematol. 2003-02-01
Online version: http://atlasgeneticsoncology.org/gene/242/bmf
